363 related articles for article (PubMed ID: 32751776)
1. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
[TBL] [Abstract][Full Text] [Related]
2. Curcumin for maintenance of remission in ulcerative colitis.
Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC
Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
Simadibrata M; Halimkesuma CC; Suwita BM
Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: A protocol of systematic review and meta-analysis.
Yang Z; Liu W; Zhou X; Zhu X; Suo F; Yao S
Medicine (Baltimore); 2020 Oct; 99(43):e22916. PubMed ID: 33120843
[TBL] [Abstract][Full Text] [Related]
5. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
6. Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Grammatikopoulou MG; Gkiouras K; Theodoridis X; Asteriou E; Forbes A; Bogdanos DP
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30424514
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
Goulart RA; Barbalho SM; Lima VM; Souza GA; Matias JN; Araújo AC; Rubira CJ; Buchaim RL; Buchaim DV; Carvalho ACA; Guiguer ÉL
J Med Food; 2021 Jul; 24(7):675-685. PubMed ID: 33155879
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Suskind DL; Wahbeh G; Burpee T; Cohen M; Christie D; Weber W
J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):277-9. PubMed ID: 23059643
[TBL] [Abstract][Full Text] [Related]
10. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Iqbal U; Anwar H; Quadri AA
Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.
Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H
Front Immunol; 2022; 13():896476. PubMed ID: 35979355
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease.
Ng SC; Lam YT; Tsoi KK; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2013 Oct; 38(8):854-63. PubMed ID: 23981095
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
Langhorst J; Wulfert H; Lauche R; Klose P; Cramer H; Dobos GJ; Korzenik J
J Crohns Colitis; 2015 Jan; 9(1):86-106. PubMed ID: 25518050
[TBL] [Abstract][Full Text] [Related]
14. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.
Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for induction of remission in ulcerative colitis.
Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
[TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
17. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK; Wang JJ
Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for maintenance of remission in ulcerative colitis.
Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
[TBL] [Abstract][Full Text] [Related]
19. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials.
Zheng T; Wang X; Chen Z; He A; Zheng Z; Liu G
J Gastroenterol Hepatol; 2020 May; 35(5):722-729. PubMed ID: 31696975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]